SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-24-005018
Filing Date
2024-04-12
Accepted
2024-04-12 16:06:28
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 tmb-20240412xs3.htm S-3 567997
2 EX-3.6 tmb-20240412xex3d6.htm EX-3.6 177426
3 EX-4.3 tmb-20240412xex4d3.htm EX-4.3 552161
4 EX-4.5 tmb-20240412xex4d5.htm EX-4.5 169756
5 EX-4.6 tmb-20240412xex4d6.htm EX-4.6 170646
6 EX-4.7 tmb-20240412xex4d7.htm EX-4.7 154044
7 EX-5.1 tmb-20240412xex5d1.htm EX-5.1 57935
8 EX-23.1 tmb-20240412xex23d1.htm EX-23.1 4278
9 EX-FILING FEES tmb-20240412xexfilingfees.htm EX-FILING FEES 59136
10 GRAPHIC tmb-20240412xex5d1002.jpg GRAPHIC 5820
11 GRAPHIC tmb-20240412xs3003.jpg GRAPHIC 8561
12 GRAPHIC tmb-20240412xs3010.jpg GRAPHIC 20923
  Complete submission text file 0001558370-24-005018.txt   1963629
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278646 | Film No.: 24841474
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)